Free Trial

ALX Oncology (ALXO) Earnings Date, Estimates & Call Transcripts

ALX Oncology logo
$0.68 -0.03 (-3.94%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ALX Oncology Earnings Summary

ALX Oncology announced Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.58, which missed analysts' consensus estimates of -$0.47 by $0.11. With a trailing EPS of -$2.47, ALX Oncology's earnings are expected to grow next year, from ($2.76) to ($2.50) per share.

Upcoming Q2
Earnings Date
Aug. 12Before Market OpensEstimated
Consensus EPS
(May. 8)
-$0.47
Actual EPS
(May. 8)
-$0.58 Missed By -$0.11

Q1 2025 Earnings Resources

ALXO Upcoming Earnings

ALX Oncology's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get ALX Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ALX Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ALXO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALX Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.61-$0.61-$0.61
Q2 20251-$0.66-$0.66-$0.66
Q3 20251-$0.68-$0.68-$0.68
Q4 20251-$0.61-$0.61-$0.61

ALX Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2025
(Estimated)
-------
5/8/2025Q1 2025-$0.47-$0.58 -$0.11-$0.58--
8/8/2024--$0.77-$0.76+$0.01-$0.76--
5/9/2024Q1 2024-$0.87-$0.71+$0.16-$0.71--
3/7/2024Q4 2023-$0.84-$0.93 -$0.09-$0.93--
11/13/2023Q3 2023-$0.86-$1.24 -$0.38-$1.24--
8/10/2023Q2 2023-$0.85-$0.84+$0.01-$0.84--

ALX Oncology Earnings - Frequently Asked Questions

ALX Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on ALXO's earnings history.

In the previous quarter, ALX Oncology (NASDAQ:ALXO) missed the analysts' consensus estimate of ($0.47) by $0.11 with a reported earnings per share (EPS) of ($0.58). Learn more on analysts' earnings estimate vs. ALXO's actual earnings.

ALX Oncology (NASDAQ:ALXO) has a recorded net income of -$134.85 million. ALXO has generated -$2.47 earnings per share over the last four quarters.

ALX Oncology's earnings are expected to grow from ($2.76) per share to ($2.50) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ALXO) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners